Home LiteratureArticle Details
PMID: 10931143 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Clinical and experimental immunology ·Vol. 121 ·No. 2 ·2000-08-00 ·Pages 283-8

Eriksson K, Nordström I, Czerkinsky C, Holmgren J

Abstract

We have studied how cholera toxin (CT) and its non-toxic cell-binding B-subunit (CTB) affect the activation of pure human T cells in an anti-CD3-driven system. CT, as opposed to CTB, strongly suppressed the proliferative responses as well as cytokine production in CD4+ and CD8+ T cells. CT however, had a differential effect on naive and activated/memory T cell subsets. Costimulation through exogenous IL-2 or through CD28 cross-linking rescued the proliferation of CT-treated naive CD45RA+ T cells, but not of activated/memory CD45RO+ cells. IL-2 production and IL-2 receptor expression were markedly reduced by CT in all T cell fractions, i.e. also in CD45RA+ cells which had maintained proliferative responses. However, the proliferative responses of CT-treated CD45RA+ T cells were IL-2-dependent, as shown by blocking experiments using anti-IL-2 antibodies. These results indicate (i) that CTB has no cytostatic effect on human T cells, (ii) that CT affects proliferation and cytokine production by two different signal pathways, and (iii) that CT might interact with a signal pathway generated through or influenced by CD45.

MeSH Terms
Adult CD4-Positive T-Lymphocytes/drug effects,immunology,metabolism CD8-Positive T-Lymphocytes/drug effects,immunology,metabolism Cell Division/drug effects Cholera Toxin/pharmacology Colforsin/pharmacology Cyclic AMP/physiology Humans Interferon-gamma/metabolism Interleukin-10/metabolism Interleukin-2/analysis Interleukin-4/metabolism Leukocyte Common Antigens/analysis,physiology Lymphocyte Activation/drug effects,physiology Lymphokines/metabolism Receptors, Antigen, T-Cell/immunology Recombinant Proteins/pharmacology Second Messenger Systems Signal Transduction/physiology T-Lymphocyte Subsets/drug effects,immunology,metabolism Th1 Cells/drug effects,immunology,metabolism Th2 Cells/drug effects,immunology,metabolism
Chemicals
Interleukin-2 Lymphokines Receptors, Antigen, T-Cell Recombinant Proteins Interleukin-10 Colforsin Interleukin-4 Interferon-gamma Cholera Toxin Cyclic AMP Leukocyte Common Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Eriksson K
Department of Medical Microbiology and Immunology, Göteborg University, Göteborg, Sweden and INSERM 4 U 364, Nice, France. kristina.eriksson@microbio.gu.se
Nordström I
Czerkinsky C
Holmgren J
References (32)
32 references, click to expand
  1. Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation.
    J Exp Med. 1974 Apr 1;139(4):801-19 PMID: 4361243
  2. Regulatory T cells and inflammatory bowel disease.
    Immunol Today. 1999 Oct;20(10):442-5 PMID: 10500290
  3. Pathophysiologic effects of lethal and immunoregulatory doses of cholera enterotoxin in the mouse.
    J Immunol. 1974 Sep;113(3):740-9 PMID: 4606891
  4. Interaction of cholera toxin and toxin derivatives with lymphocytes. II. Modulating effects of cholera toxin on in vivo humoral and cellular immune responses.
    Int Arch Allergy Appl Immunol. 1976;50(5):555-73 PMID: 5378
  5. T cell growth factor: parameters of production and a quantitative microassay for activity.
    J Immunol. 1978 Jun;120(6):2027-32 PMID: 307029
  6. The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.
    J Exp Med. 1978 Jul 1;148(1):195-206 PMID: 670885
  7. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.
    Proc Natl Acad Sci U S A. 1978 Jul;75(7):3050-4 PMID: 210449
  8. Actions of cholera toxin and the prevention and treatment of cholera.
    Nature. 1981 Jul 30;292(5822):413-17 PMID: 7019725
  9. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    J Immunol. 1984 Jun;132(6):2736-41 PMID: 6233359
  10. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
    J Immunol. 1984 Dec;133(6):2892-7 PMID: 6491278
  11. Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium.
    Proc Natl Acad Sci U S A. 1986 Aug;83(15):5673-7 PMID: 3016713
  12. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
    Immunology. 1986 Oct;59(2):301-8 PMID: 3021614
  13. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin.
    J Immunol. 1987 Dec 1;139(11):3764-70 PMID: 2824614
  14. The tissue distribution of T lymphocytes expressing different CD45 polypeptides.
    Immunology. 1989 Apr;66(4):517-25 PMID: 2523860
  15. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    J Immunol. 1989 Dec 1;143(11):3647-52 PMID: 2555413
  16. Role of the CD28 receptor in T-cell activation.
    Immunol Today. 1990 Jun;11(6):211-6 PMID: 2162180
  17. A cell culture model for T lymphocyte clonal anergy.
    Science. 1990 Jun 15;248(4961):1349-56 PMID: 2113314
  18. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    J Immunol. 1999 Jul 15;163(2):1045-52 PMID: 10395703
  19. Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.
    Infect Immun. 1999 Oct;67(10):5275-81 PMID: 10496906
  20. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.
    Eur J Immunol. 1992 Sep;22(9):2277-81 PMID: 1381311
  21. Signal transduction by lymphocyte antigen receptors.
    Cell. 1994 Jan 28;76(2):263-74 PMID: 8293463
  22. Signals and signs for lymphocyte responses.
    Cell. 1994 Jan 28;76(2):275-85 PMID: 7904901
  23. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10795-9 PMID: 7526379
  24. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
    Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7196-201 PMID: 8692968
  25. T cell antigen receptor dependent signalling in human lymphocytes: cholera toxin inhibits interleukin-2 receptor expression but not interleukin-2 synthesis by preventing activation of a protein kinase C isotype, PKC-alpha.
    Biochim Biophys Acta. 1997 Apr 24;1356(2):237-48 PMID: 9150281
  26. Single-cell analyses of CD4+ T cells from alpha beta T cell receptor-transgenic mice: a distinct mucosal cytokine phenotype in the absence of transgene-specific antigen.
    Eur J Immunol. 1997 Jul;27(7):1774-81 PMID: 9247591
  27. The role of CD45 in signal transduction.
    Adv Immunol. 1997;66:1-65 PMID: 9328639
  28. The role of CD45 and CD45-associated molecules in T cell activation.
    Immunol Cell Biol. 1997 Oct;75(5):430-45 PMID: 9429890
  29. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production.
    Immunity. 1998 Jan;8(1):115-24 PMID: 9462517
  30. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR.
    J Immunol. 1998 Mar 1;160(5):2207-14 PMID: 9498759
  31. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
    Eur J Immunol. 1999 Jun;29(6):1774-84 PMID: 10382739
  32. An improved rosetting assay for detection of human T lymphocytes.
    J Immunol Methods. 1974 Jul;5(2):131-5 PMID: 4600315
Article Info
Journal
Clinical and experimental immunology
Abbr.
Clin Exp Immunol
ISSN
0009-9104
Published
2000-08-00
Pages
283-8
Language
English
Region
England
NLM ID
0057202
PMCID
PMC1905696
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com